China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

LA PALMA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today ...

Adam Pearson’s life experiences and a recent diagnosis of a rare disease give him a unique perspective to guide the pharma company’s strategy Adam Pearson, chief strategy officer at Astellas Pharma, ...

NEW YORK CITY, NEW YORK / ACCESSWIRE / January 14, 2025 / Bionoid Pharma, Inc. (BINP) is pleased to provide a corporate update as it looks ahead to a promising year in 2025. The company remains ...

While pharmaceutical companies invest millions in drug development and commercialization, many overlook the critical connection between their products and patients: the pharmacy. This blind spot can ...

Pharma companies will need to rethink business and research and development (R&D) strategies to mitigate against the global impact that will be felt from the US Government’s Inflation Reduction Act ...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "EU (European Union) Pharmaceutical Regulations & Strategy Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's ...

Liminatus Identifies BNB Coin as Its Primary Strategic Target for Digital Asset Allocation, with Plans to Aggressively Accumulate and Hold Up to $500 Million for Long-Term Strategic Value The company ...

LA PALMA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies ...